From theory to therapy: unlocking the potential of muscarinic receptor activation in schizophrenia with the dual M1/M4 muscarinic receptor agonist xanomeline and trospium chloride and insights from clinical trials. [PDF]
Meyer JM +4 more
europepmc +1 more source
Two-step structural changes in M3 muscarinic receptor activation rely on the coupled Gq protein cycle. [PDF]
Kim YS, Yeon JH, Ko W, Suh BC.
europepmc +1 more source
Sympathovagal crosstalk: Y2-receptor blockade enhances vagal effects which in turn reduce NPY levels via muscarinic receptor activation. [PDF]
Jani NR +12 more
europepmc +1 more source
Astrocytes Reduce Store-Operated Ca2+ Entry in Microglia under the Conditions of an Inflammatory Stimulus and Muscarinic Receptor Blockade. [PDF]
Kim YJ, Shin YK, Seo E, Seol GH.
europepmc +1 more source
Selective modulation of murine intestinal M<sub>1</sub> and M<sub>3</sub> muscarinic receptor expression has divergent effects on specialized epithelial cells and body weight. [PDF]
Sampaio Moura N +11 more
europepmc +1 more source
The Bronchoprotective Effects of Dual Pharmacology, Muscarinic Receptor Antagonist and β2 Adrenergic Receptor Agonist Navafenterol in Human Small Airways. [PDF]
Jude JA +4 more
europepmc +1 more source
Muscarinic Receptor Antagonism and TRPM3 Activation as Stimulators of Mitochondrial Function and Axonal Repair in Diabetic Sensorimotor Polyneuropathy. [PDF]
Chauhan S, Calcutt NA, Fernyhough P.
europepmc +1 more source
Proof of lung muscarinic receptor occupancy by tiotropium: Translational Positron Emission Tomography studies in non-human primates and humans. [PDF]
Cselényi Z +12 more
europepmc +1 more source
Discovering Key Activation Hotspots in the M<sub>2</sub> Muscarinic Receptor. [PDF]
Sugiura Y +12 more
europepmc +1 more source
The M1 muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes. [PDF]
Marsango S +10 more
europepmc +1 more source

